Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type 1 Diabetes

Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type 1 Diabetes

Abstract Stem cell derived insulin producing cells or islets have shown promise in reversing Type 1 Diabetes (T1D), yet successful transplantation currently necessitates long‐term modulation with immunosuppressant drugs. An alternative approach to avoiding this immune response is to utilize an islet...

Full description

Bibliographic Details
Main Authors: Debkalpa Goswami, Daniel A. Domingo‐Lopez, Niamh A. Ward, Jeffrey R. Millman, Garry P. Duffy, Eimear B. Dolan, Ellen T. Roche
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Advanced Science
Subjects:
implantable therapeutic devices
macroencapsulation devices
stem cell derived islets
type 1 diabetes
Online Access:https://doi.org/10.1002/advs.202100820

Internet

https://doi.org/10.1002/advs.202100820

Similar Items